Nanobody-based CAR-T cells for cancer immunotherapy

• Główni autorzy: Pouya Safarzadeh Kozani (Autor), Abdolhossein Naseri (Autor), Seyed Mohamad Javad Mirarefin (Autor), Faeze Salem (Autor), Mojtaba Nikbakht (Autor), Sahar Evazi Bakhshi (Autor), Pooria Safarzadeh Kozani (Autor)
• Format: Książka
• Wydane: BMC, 2022-04-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Chimeric antigen receptor T-cell (CAR-T) therapy is the result of combining genetic engineering-based cancer immunotherapy with adoptive cell therapy (ACT). CAR-T therapy has been successful in treating various types of hematological cancers. CARs are receptors made of an extracellular doma...